More precisely, AFP predicted HCC recurrence in patients beyond (p < 0.001) the Milan criteria, within (p = 0.001) or beyond (p = 0.015) the UCSF criteria, or within (p = 0.001) or beyond (p = 0.023) the Up-to-7 criteria—but not in patients within (p = 0.834) the Milan criteria (Table 6). This evidence concerns the gene AFP and hepatocellular carcinoma.